Editor's note: Seeking Alpha is proud to welcome Stephan Otzen as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » AcelRx Pharmaceutic...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 120 weeks of public selections as part of this ongoing live forward-testing. In...

Company Thesis While there are over 50 million visits to U.S. hospitals for acute pain each year, AcelRx's ( ACRX ) new DSUVIA launch in Q12019 has only managed to capture $2.4 million in sales at its trailing two-quarter run-rate annualized. Current standards for acute pain management suc...